查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790277

小分子藥物研發外包市場規模、佔有率和趨勢分析報告：按工作流程、服務、治療領域、最終用途、地區和細分市場預測，2025 年至 2033 年

Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Preclinical Development), By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

小分子藥物研發外包市場概述

2024 年全球小分子藥物研發外包市場規模估計為 45.5 億美元，預計到 2033 年將達到 106.2 億美元，2025 年至 2033 年的複合年成長率為 10.03%。研發支出的增加、藥物開發需求的不斷成長以及向虛擬製藥模式的轉變正在推動市場的發展。

其他市場成長要素包括註冊研究數量的增加、小分子藥物核准的擴大、醫療技術的進步、正在研究的疾病數量的增加以及對新型療法的需求。目前，小分子藥物是製藥業的基石。這些以小分子為特徵的有機化合物作為治療劑具有多種優勢。這些分子具有諸如高口服生物有效性、靈活的給藥方案以及參與細胞內通路的能力等優勢，使其適用於多種疾病，尤其是癌症、感染疾病和神經系統疾病。

此外，藥物發現在這些小分子藥物的開發中起著關鍵作用，涉及複雜的步驟和最尖端科技，以配製有效的治療方法並加速開發平臺。因此，許多製藥和生物製藥公司擴大與外包公司合作，這些公司在管理藥物發現的早期階段方面擁有專業知識，包括標靶識別、先導化合物到先導化合物的過程、先導化合物最佳化和核准過程。例如，2024 年，美國FDA 藥品評估和研究中心核准了50 個新分子實體，包括 32 個化學實體和 18 個生物實體。此外，小分子在 NCE 中引起了極大的關注和市場佔有率，佔 91%（31 種產品），其餘藥物為胜肽和核酸。

此外，隨著製藥公司意識到獲得成功藥物開發和商業化所必需的額外能力所帶來的益處，製藥業的外包業務也日益蓬勃發展。外包能帶來顯著的製造效益，包括提供專業知識、改善現金流管理、降低投資風險。此外，為早期技術和產品開發成本高昂的內部能力，在開發過程中會帶來巨大風險。因此，外包正成為降低產品創新風險的新興選擇。此外，公司在確定當前和未來產品供應規模以及市場滲透率方面往往面臨挑戰，這使得內部製造的設計和規模擴展變得複雜。因此，外包正成為產品創新的首選方案。

此外，創新技術、慢性病和感染疾病的日益普及以及對新型治療方法日益成長的需求正在支撐市場成長。人工智慧、機器學習和高效能篩檢的進步正在簡化熱門化合物的識別和先導化合物的最佳化流程，從而支援市場成長。此外，精準醫療和基於人工智慧的篩檢方法的進步進一步提高了藥物發現過程的效率。同樣，藥物設計、預測模型和精準醫療領域的進步正在增加外包合作夥伴在藥物發現和開發早期階段的貢獻。預計這些因素將在預計期內推動市場成長。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 小分子藥物研發外包市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗量分析（2024年）
    • 各地區臨床試驗總數
    • 各階段臨床試驗總數
    • 按研究設計分類的臨床試驗總數
    • 按主要治療領域分類的臨床試驗總數
  • 定價模式分析
  • 科技
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章小分子藥物研發外包市場：工作流程的估計與趨勢分析

  • 小分子藥物研發外包市場（依工作流程）：細分儀表板
  • 小分子藥物研發外包市場（依工作流程）：波動分析
  • 按工作流程，2021-2033 年
  • 目標識別與篩檢
  • 對象檢驗和功能資訊科學
  • 潛在客戶資格審查和候選人最佳化
  • 臨床前開發
  • 其他

第5章小分子藥物研發外包市場：依服務進行的估算與趨勢分析

  • 小分子藥物研發外包市場（按服務）：細分儀表板
  • 小分子藥物研發外包市場（按服務）：波動分析
  • 按服務分類，2021-2033 年
  • 化學服務
  • 生物服務

第6章：小分子藥物研發外包市場：依治療領域的估計與趨勢分析

  • 小分子藥物研發外包市場（依治療領域）：細分儀表板
  • 小分子藥物研發外包市場（依治療領域）：波動分析
  • 依治療領域，2021-2033年
  • 呼吸系統
  • 疼痛和麻醉
  • 腫瘤學
  • 眼科
  • 血液學
  • 心血管系統
  • 內分泌
  • 胃腸道
  • 免疫調節
  • 抗感染
  • 中樞神經系統
  • 皮膚科
  • 泌尿生殖系統

第7章小分子藥物研發外包市場：依最終用途的估計與趨勢分析

  • 小分子藥物研發外包市場（依最終用途）：細分儀表板
  • 小分子藥物研發外包市場（依最終用途）：波動分析
  • 依最終用途，2021-2033 年
  • 製藥和生物技術公司
  • 學術機構

第8章：小分子藥物研發外包市場：區域、估價與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2033 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • WuXi AppTec
    • Pharmaceutical Product Development, LLC
    • Charles River Laboratories
    • Laboratory Corporation of America Holdings（Covance）
    • Eurofins
    • Evotec
    • Albany Molecular Research（Curia）
    • GenScript BIoTech
    • Pharmaron
    • Syngene International
    • Dalton Pharma Services
    • Oncodesign
    • Jubilant Biosys
    • Domainex
    • GenScript BIoTech
    • Merck & Co., Inc.
    • QIAGEN
    • Dr. Reddy Laboratories Ltd.
    • Pharmaron Beijing Co., Ltd.
    • TCG Lifesciences Pvt Ltd.

第9章 主要建議

Product Code: GVR-4-68040-672-8

Small Molecule Drug Discovery Outsourcing Market Summary

The global small molecule drug discovery outsourcing market size was estimated at USD 4.55 billion in 2024, and is projected to reach USD 10.62 billion by 2033, growing at a CAGR of 10.03% from 2025 to 2033. Rising research and development expenses, an increasing need for drug development, and a transition toward virtual pharmaceutical models drive the market.

Some other factors contributing to market growth are a rising number of registered studies, growing approval of small molecule drugs, advancements in medical technology, an upsurge in diseases under investigation, and the imperative for novel treatments. Currently, small molecule drugs have been the cornerstone of the pharmaceutical industry. These organic compounds, characterized by their low molecular weight, offer several advantages as therapeutic agents. These molecules provide advantages such as high oral bioavailability, adaptable dosing regimens, and the capability to engage intracellular pathways, making them applicable to a broad spectrum of diseases, particularly in areas like cancer, infections, and neurological disorders.

Besides, drug discovery plays a crucial role in developing these small molecule drugs, encompassing complex stages and cutting-edge technologies to formulate effective therapies and accelerate R&D pipelines. Thus, many pharmaceutical and biopharmaceutical companies are increasingly partnering with outsourcing companies specializing in the expertise to manage early discovery phases, including target identification, hit-to-lead processes, lead optimization, and the approval process. For instance, in 2024, the U.S. FDA Center for Drug Evaluation and Research approved 50 new molecular entities, consisting of 32 chemical entities & 18 biologic entities. Besides, of the NCEs, small molecules gained major attention and share, making up 91% (31 drugs), with the remaining drugs comprising peptides and nucleic acids.

Moreover, outsourcing in the pharmaceutical industry is gaining momentum as companies recognize the benefits of acquiring additional competencies essential for successful drug development and commercialization. Outsourcing provides specialized expertise, helps improve cash flow management, and offers significant manufacturing advantages, including reducing investment risks. Besides, developing costly in-house capabilities for early-stage technologies and products involves considerable risks throughout development. These factors have led to outsourcing as an emerging risk-averse alternative for product innovations. Moreover, companies often face challenges in determining the necessary scale for current and future product offerings or market penetration, complicating the design and scaling of in-house manufacturing. As a result, outsourcing has become a preferred option for product innovation.

Furthermore, innovative technologies, the rising prevalence of chronic and infectious diseases, and the growing need for new therapies support market growth. Advances such as artificial intelligence, machine learning, and high-throughput screening are streamlining the hit identification and lead optimization processes, supporting the market growth. Also, the advancement of precision medicine and AI-driven screening methods has further enhanced the efficiency of the discovery process. Similarly, advancements in drug design, predictive modeling, and precision medicine are enhancing the contributions of outsourcing partners in the early stages of drug discovery and development. Such factors are expected to drive the market growth over the estimated time period.

Global Small Molecule Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global small molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, end use, and region:

  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Service
    • 1.2.3. Therapeutics Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Small Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising R&D costs in pharmaceutical/biopharmaceutical Industry
      • 3.2.1.2. Increasing demand for outsourcing services in drug development
      • 3.2.1.3. Technological advancements in drug discovery
      • 3.2.1.4. Rising shortening time-to-market pressures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Intellectual property (IP) and data security concerns
      • 3.2.2.2. Limited standardization and reproducibility
      • 3.2.2.3. Integration challenges with internal R&D pipelines
  • 3.3. Clinical Trials Volume Analysis (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Small Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Small Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 5.1. Small Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 5.2. Small Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 5.3. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Chemistry Services
    • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Biology Services
    • 5.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Small Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 6.3. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
  • 6.4. Respiratory system
    • 6.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pain and Anesthesia
    • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ophthalmology
    • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Hematology
    • 6.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Endocrine
    • 6.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Gastrointestinal
    • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Immunomodulation
    • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Anti-infective
    • 6.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Central Nervous System
    • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.15. Dermatology
    • 6.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.16. Genitourinary System
    • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Small Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. Small Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. Small Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 7.3. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology companies
    • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Academic Institutes
    • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Small Molecule Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. WuXi AppTec
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Pharmaceutical Product Development, LLC
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Charles River Laboratories
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Laboratory Corporation of America Holdings (Covance)
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Eurofins
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Evotec
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Albany Molecular Research (Curia)
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. GenScript Biotech
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Pharmaron
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Syngene International
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Dalton Pharma Services
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Oncodesign
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Jubilant Biosys
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Domainex
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. GenScript Biotech
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. Merck & Co., Inc.
      • 9.3.16.1. Company Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Service Benchmarking
      • 9.3.16.4. Strategic Initiatives
    • 9.3.17. QIAGEN
      • 9.3.17.1. Company Overview
      • 9.3.17.2. Financial Performance
      • 9.3.17.3. Service Benchmarking
      • 9.3.17.4. Strategic Initiatives
    • 9.3.18. Dr. Reddy Laboratories Ltd.
      • 9.3.18.1. Company Overview
      • 9.3.18.2. Financial Performance
      • 9.3.18.3. Service Benchmarking
      • 9.3.18.4. Strategic Initiatives
    • 9.3.19. Pharmaron Beijing Co., Ltd.
      • 9.3.19.1. Company Overview
      • 9.3.19.2. Financial Performance
      • 9.3.19.3. Service Benchmarking
      • 9.3.19.4. Strategic Initiatives
    • 9.3.20. TCG Lifesciences Pvt Ltd.
      • 9.3.20.1. Company Overview
      • 9.3.20.2. Financial Performance
      • 9.3.20.3. Service Benchmarking
      • 9.3.20.4. Strategic Initiatives

Chapter 9 Key Recommendations

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 4 Global Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 6 Global Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 8 North America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 10 North America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 North America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 12 North America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 14 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 16 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 18 Canada Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 19 Canada Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 20 Canada Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 22 Mexico Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 23 Mexico Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 24 Mexico Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 27 Europe Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Europe Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 29 Europe Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 31 UK Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 UK Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 33 UK Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 35 Germany Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 36 Germany Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 37 Germany Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 39 France Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 France Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 41 France Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 43 Italy Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 44 Italy Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 45 Italy Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 47 Spain Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 48 Spain Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 49 Spain Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 51 Denmark Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52 Denmark Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 53 Denmark Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 55 Sweden Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 56 Sweden Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 57 Sweden Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 58 Norway Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 59 Norway Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 60 Norway Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 61 Norway Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 68 Japan Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 69 Japan Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 70 Japan Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 71 China Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 72 China Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 73 China Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 74 China Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 75 India Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 76 India Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 77 India Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 78 India Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 79 Thailand Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 80 Thailand Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81 Thailand Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 82 Thailand Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 84 South Korea Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 85 South Korea Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 86 South Korea Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Australia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 88 Australia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 89 Australia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 90 Australia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 93 Latin America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 94 Latin America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 95 Latin America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 97 Brazil Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 98 Brazil Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 99 Brazil Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 101 Argentina Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 102 Argentina Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 103 Argentina Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 110 South Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 111 South Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 112 South Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 118 UAE Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 119 UAE Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 120 UAE Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Small Molecule Drug Discovery Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Small Molecule Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
  • Fig. 20 Small Molecule Drug Discovery Outsourcing Market: Workflow movement analysis
  • Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Small Molecule Drug Discovery Outsourcing Market: Service outlook and key takeaways
  • Fig. 27 Small Molecule Drug Discovery Outsourcing Market: Service movement analysis
  • Fig. 28 Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Small Molecule Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
  • Fig. 31 Small Molecule Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
  • Fig. 32 Respiratory system Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Small Molecule Drug Discovery Outsourcing Market: End Use outlook and key takeaways
  • Fig. 46 Small Molecule Drug Discovery Outsourcing Market: End Use movement analysis
  • Fig. 47 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48
  • Fig. 49 Regional Marketplace: Key Takeaways
  • Fig. 50 North America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Canada Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Mexico Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Europe Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 UK Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Germany Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 France Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Sweden Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Norway Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Asia Pacific Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 China Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 India Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Australia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Latin America Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Argentina Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 MEA Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Service heat map analysis
  • Fig. 103 Strategic framework